Cargando…
Synergistic combination therapy of lung cancer using paclitaxel- and triptolide-coloaded lipid–polymer hybrid nanoparticles
PURPOSE: Non-small cell lung cancer (NSCLC) accounts for the majority of lung cancer. Lipid–polymer hybrid nanoparticles (LPNs) combine the advantages of both polymeric nanoparticles and liposomes into a single delivery platform. In this study, we engineered LPNs as the co-delivery system of paclita...
Autores principales: | Liu, Jia, Cheng, Hao, Han, Le, Qiang, Zhun, Zhang, Xinwei, Gao, Wei, Zhao, Kun, Song, Yangrong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6161729/ https://www.ncbi.nlm.nih.gov/pubmed/30288024 http://dx.doi.org/10.2147/DDDT.S172199 |
Ejemplares similares
-
Codelivery of doxorubicin and triptolide with reduction-sensitive lipid–polymer hybrid nanoparticles for in vitro and in vivo synergistic cancer treatment
por: Wu, Bo, et al.
Publicado: (2017) -
Fabrication, Optimization, and Evaluation of Paclitaxel
and Curcumin Coloaded PLGA Nanoparticles for Improved Antitumor Activity
por: Hu, Haiyang, et al.
Publicado: (2022) -
Synergistic anti-glioma effect of a coloaded nano-drug delivery system
por: Xu, Huae, et al.
Publicado: (2016) -
Folate-modified lipid–polymer hybrid nanoparticles for targeted paclitaxel delivery
por: Zhang, Linhua, et al.
Publicado: (2015) -
Lactoferrin- and RGD-comodified, temozolomide and vincristine-coloaded nanostructured lipid carriers for gliomatosis cerebri combination therapy
por: Zhang, Jicai, et al.
Publicado: (2018)